Evaluation of Oral Mucosal Lesions Using the IllumiScan

autofluorescence coefficient of variation epithelial dysplasia fluorescence visualisation device oral mucosal lesion oral squamous cell carcinoma

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
21 08 2022
Historique:
received: 14 06 2022
revised: 03 08 2022
accepted: 18 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

We evaluated whether fluorescence intensity (FI) and its coefficient of variation (CV) can be used to diagnose squamous cell carcinoma (SCC) through IllumiScan®, an oral mucosa fluorescence visualisation (FV) device. Overall, 190 patients with oral mucosal lesions (OMLs; SCC, 59; non-SCC OMLs, 131) and 49 patients with normal oral mucosa (NOM) were enrolled between January 2019 and March 2021. The FI of the images was analysed using image analysis software. After establishing regions of interest for SCC, non-SCC, and NOM, the average FI, standard deviation (SD), and CV were compared. There was a significant difference in the average FI for all pairs of comparisons. The SD was not significantly different between the SCC and NOM groups (p = 0.07). The CV differed significantly for NOM (p < 0.001) and non-SCC groups (p < 0.001) relative to the SCC group but was not different between NOM and non-SCC groups (p = 0.15). Univariate analysis of SCC and non-SCC groups showed significant differences for all factors, except age. However, multivariate analysis showed a significant intergroup difference only in the CV (p = 0.038). Therefore, analysing the CV in FV images of OML may be useful for the diagnosis of oral cancer.

Identifiants

pubmed: 36012046
pii: ijerph191610414
doi: 10.3390/ijerph191610414
pmc: PMC9408154
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2 Suppl):121-8
pubmed: 21781457
Oral Dis. 2020 Feb 11;:
pubmed: 32045089
J Oral Pathol Med. 2018 Feb;47(2):104-116
pubmed: 29130527
J Am Dent Assoc. 2012 Dec;143(12):1332-42
pubmed: 23204089
Oncol Lett. 2020 Sep;20(3):2153-2160
pubmed: 32782532
Clin Exp Dent Res. 2018 Aug 15;4(5):174-181
pubmed: 30386639
Dent J (Basel). 2019 Sep 04;7(3):
pubmed: 31487927
Int J Oral Maxillofac Surg. 2020 Apr;49(4):515-521
pubmed: 31500953
J Oral Biol Craniofac Res. 2020 Apr-Jun;10(2):99-103
pubmed: 32211285
Photodiagnosis Photodyn Ther. 2017 Mar;17:1-4
pubmed: 27989864
Photodiagnosis Photodyn Ther. 2018 Mar;21:19-27
pubmed: 29079347
Int J Clin Oncol. 2020 Sep;25(9):1604-1611
pubmed: 32451767
Annu Rev Phys Chem. 1996;47:555-606
pubmed: 8930102
J Am Dent Assoc. 2010 Feb;141(2):151-6
pubmed: 20123872
Cancer Res. 1984 Jun;44(6):2259-65
pubmed: 6372991
Med Oral Patol Oral Cir Bucal. 2005 Mar-Apr;10(2):95-102
pubmed: 15735540
Sci Rep. 2019 May 24;9(1):7833
pubmed: 31127170
Transl Cancer Res. 2022 Jun;11(6):1603-1615
pubmed: 35836514
Indian J Community Med. 2021 Oct-Dec;46(4):622-625
pubmed: 35068722
Arch Oral Biol. 1971 Apr;16(4):423-34
pubmed: 5281213
J Oral Pathol Med. 1992 Apr;21(4):160-3
pubmed: 1376363
Bull Tokyo Dent Coll. 2022 Mar 8;63(1):1-12
pubmed: 35173082
Int J Environ Res Public Health. 2020 Dec 08;17(24):
pubmed: 33302498
Med Oral Patol Oral Cir Bucal. 2016 Jul 01;21(4):e447-55
pubmed: 26946209
J Oral Maxillofac Pathol. 2021 Sep-Dec;25(3):548-549
pubmed: 35281151
Cancer. 1998 Apr 15;82(8):1454-9
pubmed: 9554520
Head Neck. 2004 Mar;26(3):205-15
pubmed: 14999795
Photodiagnosis Photodyn Ther. 2021 Mar;33:102073
pubmed: 33232819
Oral Oncol. 2017 Dec;75:67-74
pubmed: 29224826
J Craniomaxillofac Surg. 2017 Sep;45(9):1526-1530
pubmed: 28688861
Anticancer Res. 2019 May;39(5):2519-2525
pubmed: 31092448
J Oral Pathol Med. 2014 Jan;43(1):7-13
pubmed: 23750637
J Am Dent Assoc. 2010 May;141(5):509-20
pubmed: 20436098
Int J Environ Res Public Health. 2021 Nov 10;18(22):
pubmed: 34831531
Am J Surg Pathol. 2005 Feb;29(2):167-78
pubmed: 15644773
Oral Oncol. 2013 Nov;49(11):1083-7
pubmed: 24054332
Cureus. 2018 Aug 6;10(8):e3111
pubmed: 30338186
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683

Auteurs

Yuki Taguchi (Y)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Shigeaki Toratani (S)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Kensaku Matsui (K)

Department of Dentistry and Oral Surgery, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan.

Seiya Hayashi (S)

Department of Dentistry and Oral Surgery, JA Onomichi General Hospital, Onomichi 722-8508, Japan.

Natsuki Eboshida (N)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Atsuko Hamada (A)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Nanako Ito (N)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Fumitaka Obayashi (F)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Naohiro Kimura (N)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Souichi Yanamoto (S)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima 734-8551, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH